
Zyntex provides high-purity Prednisone, a potent synthetic glucocorticoid. This prodrug is converted by the liver into active prednisolone, making it a cornerstone therapy for a wide range of conditions, including asthma, rheumatoid arthritis, and certain cancers.
In the field of immunology and internal medicine, Prednisone is recognized as one of the most effective agents for rapid symptomatic relief. Chemically, Prednisone is a prodrug; once ingested, it is rapidly converted by the 11-β-HSD enzymes in the liver into its active form, prednisolone. Its primary mechanism involves binding to cytoplasmic glucocorticoid receptors, which then translocate to the nucleus to modulate gene expression. This process inhibits the production of pro-inflammatory cytokines and reduces the migration of polymorphonuclear leukocytes. Zyntex ensures a high-purity crystalline powder that provides consistent bioavailability, which is critical for patients requiring precise dose titration during long-term “tapering” regimens.
Beyond its anti-inflammatory properties, Prednisone plays a vital role in oncology and hematology. It is a standard component of combination chemotherapy protocols (such as CHOP) for treating lymphomas and leukemias, where it induces apoptosis in malignant lymphoid cells. At Zyntex, we maintain rigorous quality standards to ensure our API is free from degradants that could affect stability in shelf-stable tablets. Because Prednisone has a significant impact on metabolic processes—including glucose metabolism and bone density—the purity and consistency of the API are paramount to ensuring patient safety. Consequently, our product is the preferred choice for manufacturers producing high-reliability steroids for chronic disease management. Finally, our global supply chain guarantees that this essential medicine is available to meet the needs of diverse therapeutic markets.
This essential glucocorticoid API is utilized across a broad spectrum of medical specialties:
A cornerstone for managing acute flare-ups of rheumatoid arthritis, systemic lupus erythematosus (SLE), and vasculitis.
Crucial for the treatment of severe asthma, COPD exacerbations, and interstitial lung diseases such as sarcoidosis.
Used as an antineoplastic agent in blood cancers and as supportive care to reduce tumor-associated edema and chemotherapy-induced nausea.
Indicated for severe, incapacitating allergic conditions such as Stevens-Johnson syndrome and drug hypersensitivity reactions.
| Parameter | Specification Standard |
|---|---|
| Product Name | Prednisone |
| CAS Number | 53-03-2 |
| Molecular Formula | C21H26O5 |
| Assay (HPLC) | 98.0% – 102.0% (USP Standard) |
| Appearance | White to practically white crystalline powder |
🔬 Scientific Data: For detailed pharmacokinetics and the metabolic pathway of its conversion to prednisolone, consult: PubChem Entry: Prednisone (External Link)